The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Abstract
The clinical manifestations of Wilson disease (WD) are varied and challenging. We conducted the current study to present the phenotypic characteristics and follow-up for a large cohort of patients with WD. We reviewed the medical records of 282 cases of WD (male:female ratio, 196:86) for clinical features, investigations, treatment, and outcome data. The clinical presentations were as follows: hepatic, 42 (14.9%); hepato-neurologic, 10 (3.5%); neurologic, 195 (69.1%); pure psychiatric, 7 (2.4%); osseomuscular, 6 (2.1%); and "presymptomatic," 15 (5.3%). Mean age was 15.9 years. Presymptomatic patients and those with the hepatic form of WD were younger and patients with osseomuscular and psychiatric forms were older than neurologic patients. The mean duration of illness at the time of diagnosis was 28 months. Predominant neurologic features were as follows: parkinsonism, 62.3%; dystonia, 35.4%; cerebellar, 28%; pyramidal signs, 16%; chorea, 9%; athetosis, 2.2%; myoclonus, 3.4%; and behavioral abnormalities, 16%. Kayser-Fleischer (KF) rings were seen as follows: neurologic patients, 100%; hepatic patients, 86%; and presymptomatic patients, 59%. Positive family history was noted in 47% and consanguinity in 54%. Patients born of consanguineous parents had an earlier age of onset and shorter duration of illness before presentation. Serum ceruloplasmin was decreased in 93% and 24-hour urinary copper excretion was increased in 70% of patients. Neuroimaging (computed tomography/magnetic resonance imaging) and electrophysiologic abnormalities were seen in many patients. Overall, 195 patients were on D-penicillamine therapy and 182 on zinc sulphate. Follow-up data, available for 225 patients, for a mean duration of 46 months, revealed improvement in 176, no change in 20, and deterioration in 6. Twenty-three patients died. To conclude, despite increased awareness and recognition and significant inroads into therapeutic frontiers, follow-up remains poor in developing countries and a return to previous level of functioning is not universal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WILSON, S. A. K. (1912) · Brain · doi:10.1093/brain/34.4.295 · Cited by 1,136
Penicillamine, a new oral therapy for Wilson's disease
Walshe, J. M. (1956) · The American Journal of Medicine · doi:10.1016/0002-9343(56)90066-3 · Cited by 707
Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520170020016 · Cited by 335
BREWER, G. J., & YUZBASIYAN-GURKAN, V. (1992) · Medicine · doi:10.1097/00005792-199205000-00004 · Cited by 303
Genetic and molecular basis for copper toxicity
Harris, Z., & Gitlin, J. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.836 · Cited by 285
Starosta-Rubinstein, S. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520160007005 · Cited by 258
Wilson's disease: the problem of delayed diagnosis.
Walshe, J. M., & Yealland, M. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.692 · Cited by 232
Chelation treatment of neurological Wilson's disease
Walshe, J. M., & Yealland, M. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068791 · Cited by 148
Cranial MR findings in Wilson's disease
Saatçi, I., Topçu, M., Baltaoglu, F. F., Köse, G., Yalaz, K., Renda, Y., & Besim, A. (1997) · Acta Radiologica · doi:10.1080/02841859709172059 · Cited by 104
Geographic variations in Wilson's disease
Chu, N., & Hung, T.-P. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90145-o · Cited by 38
Cited by
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Wilson's disease and other neurological copper disorders
Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,036
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Lorincz, M. T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05109.x · Cited by 370
A genetic study of Wilson’s disease in the United Kingdom
Coffey, A. J., Durkie, M., Hague, S., McLay, K., Emmerson, J., Lo, C., Klaffke, S., Joyce, C. J., Dhawan, A., Hadzic, N., et al. (2013) · Brain · doi:10.1093/brain/awt035 · Cited by 361
Metadata
- Authors
- Taly, A. B., Meenakshi-Sundaram, S., Sinha, S., Swamy, H. S., & Arunodaya, G. R.
- Venue
- Medicine
- Published
- 2007-03
- Volume
- 86
- Issue
- 2
- Pages
- 112-121
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W1985366957
- Cited by
- 281
- References
- 11
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades. https://app.cochat.ai/papers/10.1097/md.0b013e318045a00e
- The paper
- Taly, A. B., Meenakshi-Sundaram, S., Sinha, S., Swamy, H. S., & Arunodaya, G. R. (2007). Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades. Medicine. https://doi.org/10.1097/md.0b013e318045a00e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.